Keros Therapeutics Operating Cycle Over Time
| KROS Stock | USD 17.04 0.11 0.64% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Keros Therapeutics Performance and Keros Therapeutics Correlation. Is there potential for Biotechnology market expansion? Will Keros introduce new products? Factors like these will boost the valuation of Keros Therapeutics. Expected growth trajectory for Keros significantly influences the price investors are willing to assign. Understanding fair value requires weighing current performance against future potential. All the valuation information about Keros Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 1.56 | Revenue Per Share | Quarterly Revenue Growth 35.758 | Return On Assets | Return On Equity |
Investors evaluate Keros Therapeutics using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Keros Therapeutics' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. External factors like market trends, sector rotation, and investor psychology can cause Keros Therapeutics' market price to deviate significantly from intrinsic value.
Understanding that Keros Therapeutics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Keros Therapeutics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Keros Therapeutics' market price signifies the transaction level at which participants voluntarily complete trades.
Cross Equities Operating Cycle Analysis
Compare Keros Therapeutics and related stocks such as Regenxbio, Verastem, and Absci Corp Operating Cycle Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RGNX | 65.2407 | 65.2407 | 65.2407 | 65.2407 | 112 | 350 | 758 | 1.2 K | 231 | 395 | 209 | 25.1734 | 98.0854 | 107 | 94.4695 | 109 | 103 |
| VSTM | 207 | 207 | 207 | 207 | 207 | 207 | 207 | 207 | 207 | 455 | 0.9855 | 91.7389 | 4.3586 | 7.3 | 7.3 | 8.4 | 7.98 |
| ABSI | 39.335 | 39.335 | 39.335 | 39.335 | 39.335 | 39.335 | 39.335 | 39.335 | 39.335 | 39.335 | 122 | 195 | 192 | 140 | 140 | 126 | 110 |
| NAGE | 108 | 221 | 265 | 152 | 182 | 338 | 355 | 289 | 245 | 222 | 194 | 220 | 226 | 185 | 117 | 105 | 169 |
| CTMX | 97.4155 | 97.4155 | 97.4155 | 97.4155 | 135 | 35.2127 | 56.1221 | 51.6696 | 0.595 | 0.0825 | 4.2567 | 7.7281 | 247 | 12.3765 | 8.2011 | 9.43 | 8.96 |
| VTYX | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| MLTX | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| CRVS | 1.8 K | 1.8 K | 1.8 K | 1.8 K | 1.8 K | 1.8 K | (369) | (369) | (259) | (259) | (259) | (259) | (259) | (259) | (259) | (298) | (283) |
| OLMA | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| RIGL | 95.394 | 294 | 294 | 294 | 254 | 2.5643 | 1.2 K | 1.2 K | 1.2 K | 608 | 722 | 2.3 K | 2 K | 379 | 202 | 182 | 354 |
Keros Therapeutics and related stocks such as Regenxbio, Verastem, and Absci Corp Operating Cycle description
My Equities
My Current Equities and Potential Positions
| Keros Therapeutics | KROS |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | 1050 Waltham Street, |
| Exchange | NASDAQ Exchange |
USD 17.04
Additional Tools for Keros Stock Analysis
When running Keros Therapeutics' price analysis, check to measure Keros Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Keros Therapeutics is operating at the current time. Most of Keros Therapeutics' value examination focuses on studying past and present price action to predict the probability of Keros Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Keros Therapeutics' price. Additionally, you may evaluate how the addition of Keros Therapeutics to your portfolios can decrease your overall portfolio volatility.